Venus Medtech (Hangzhou) Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 255.61 million compared to CNY 209.97 million a year ago. Net loss was CNY 350.19 million compared to CNY 199.93 million a year ago.

Basic loss per share from continuing operations was CNY 0.8 compared to CNY 0.46 a year ago.